Related Experiment Video

Updated: Jul 2, 2025

Quantification of Hypopigmentation Activity In Vitro
06:08

Quantification of Hypopigmentation Activity In Vitro

Published on: March 6, 2019

11.3K

Arctigenin Induces Apoptosis in Melanoma Cells by Reducing the Expression of BCL-2 and VEGF

Yang Gao1, He-Peng Wang1, Hai-Fei Wang1

  • 1Hebei Academy of Chinese Medicine Sciences, No.209, Jianhua Street, Yuhua District, Shijiazhuang, Hebei 050038, P. R. China.

Transplantation Proceedings
|February 17, 2024
PubMed
Abstract

Insights

Arctigenin effectively inhibits melanoma cell proliferation and promotes apoptosis in B16-F10 cells. This anti-cancer effect is linked to reduced expression of BCL-2 and vascular endothelial growth factor (VEGF).

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Melanoma is a significant skin cancer with limited treatment options.
  • Arctigenin, a natural compound, warrants investigation for its anti-cancer properties.

Purpose of the Study:

  • To evaluate the in vitro biological effects of arctigenin on B16-F10 melanoma cells.
  • To elucidate the underlying molecular mechanisms of arctigenin's action.

Main Methods:

  • B16-F10 melanoma cells were treated with varying concentrations of arctigenin.
  • Cell proliferation and apoptosis were assessed using CCK-8 and cell loss assays.
  • Western blot analysis was performed to measure BCL-2 and vascular endothelial growth factor (VEGF) expression.

Main Results:

  • Arctigenin significantly inhibited B16-F10 cell proliferation in a dose-dependent manner.
  • Arctigenin significantly promoted apoptosis in B16-F10 cells, also in a dose-dependent manner.
  • Expression levels of BCL-2 and VEGF were significantly reduced by arctigenin treatment.

Conclusions:

  • Arctigenin demonstrates potent anti-proliferative and pro-apoptotic effects on melanoma cells.
  • The mechanism involves the downregulation of BCL-2 and VEGF expression.
  • Arctigenin shows potential as a therapeutic agent for melanoma.

More Related Videos

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

414
A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration08:55

A Novel In Vitro Wound Healing Assay to Evaluate Cell Migration

Published on: March 17, 2018

22.0K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K